Molecular Pharmacology (USA) Limited, a development stage company, develops and commercializes pain and inflammation management products primarily in Australia and the United States. The company, through its subsidiary, Molecular Pharmacology Pty. Ltd., develops analgesic and anti-inflammatory molecule, known as Tripeptofen for the treatment of common every-day pain. Its products are available in various dosage forms, formulations, line extensions, and package configurations. The company focuses...
Industry: Shell Companies
Sector: Financial Services
Phone: 61 8 9443 3011
Address:
Drug Discovery Centre, 284 Oxford Street Leederville, Perth, Australia
